Pages

Friday, June 26, 2015

Roche's Lucentis Could Get Boost From House Compounding Directives To FDA


Roche's Lucentis Could Get Boost From House Compounding Directives To FDA


Executive Summary

Compounding pharmacies – and makers of particular products – would see favorable guidance changes under instructions to FDA in House appropriations report.

Purchase this Article

$50.00   

No comments:

Post a Comment